Production of nuclear medicine generators has resumed at the Australian Nuclear Science and Technology Organisation (Ansto) near Sydney after a short-term fault stopped production.

Ansto said last week that a batch of nuclear medicine generators, which transport nuclear medicine to more than 200 hospitals and nuclear medicine facilities around the country and region, did not pass routine quality checks and therefore were not dispatched to customers.

Generators contain molybdenum-99 (Mo-99), which decays to technetium-99m (Tc-99), about 12,000 potential doses of which are sent to hospitals and nuclear medicine centres around Australia each week.